Cancer Research UK and Cancerbackup for strategic alliance

19 March 2007

Cancer patients seeking facts about their diagnosis and treatment will soon be able to receive information prescriptions due to a new partnership between Britain's leading cancer charities, Cancer Research UK and Cancerbackup.

Almost two thirds of cancer patients do not fully understand what their diagnosis mean , notes a joint statement. To reduce the uncertainty and fear felt by cancer patients, the two charities are launching a major initiative to provide the best quality cancer information for patients in the UK.

Information prescriptions will help to ensure patients receive immediate, relevant information from their doctors and nurses, as well as to signpost patients to additional information and support, empowering people to take control of their illness. Peoples will receive information prescriptions at key points in their illness as the focus of their care and treatment needs change.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight